By analyzing the correlation between SPP1 expression and patients’ clinical characteristics, we found that there was no significant difference between the two groups in age, FIGO stage, volume of ascites, bowel mesenteric metastasis, lymph node metastasis and residual disease. Here, SPP1 is linked to metastatic malignant neoplasm in the lymph nodes.